Cerus Corporation (CERS) vs NeuroPace, Inc. (NPCE)
A side-by-side comparison of Cerus Corporation and NeuroPace, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERS
Cerus Corporation
$2.36HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NPCE
NeuroPace, Inc.
$13.04HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — CERS vs NPCE
growth of $100 · dividends reinvested · last 5yCERS -62.6% (-17.9%/yr)NPCE -47.0% (-11.9%/yr)NPCE compounded faster over this window
CERS NPCE
CERS vs NPCE: by the numbers
- •CERS is the larger company ($476M vs $445M market cap).
- •Both run net losses; CERS's is the smaller (-3.06% vs -19.34% net margin).
- •NPCE grew revenue faster over the past five years (15.85% vs 15.74% CAGR).
Metrics side by side
Valuation
| Metric | CERS | NPCE |
|---|---|---|
| P/S ratio | 2.15 | 4.50 |
| P/B ratio | 6.79 | 37.41 |
| EV / EBITDA | 8097.24 | N/A |
Profitability
| Metric | CERS | NPCE |
|---|---|---|
| Gross margin | 52.05% | 79.63% |
| Operating margin | -0.73% | -15.26% |
| Net margin | -3.06% | -19.34% |
| ROE | -9.69% | -160.85% |
| ROIC | -1.08% | -18.95% |
Growth (annualized)
| Metric | CERS | NPCE |
|---|---|---|
| Revenue CAGR (5Y) | 15.74% | 15.85% |
| Total return CAGR (5Y) | -17.30% | -4.94% |
Frequently asked
- Which has grown faster, CERS or NPCE?
- Over the past five years, NPCE grew revenue faster — CERS at a 15.74% CAGR versus NPCE at 15.85%.
- How have CERS and NPCE total returns compared?
- Over the past 5 years, CERS delivered -17.30% and NPCE delivered -4.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cerus ROENeuroPace ROECerus operating marginNeuroPace operating marginCerus revenue growthNeuroPace revenue growthCerus free cash flowNeuroPace free cash flow
Cerus & NeuroPace appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.